Diabetes
Diabetes Care Standards 2024: Evidence-Based Guide
Diabetes Care Standards 2024: Evidence-Based Guidelines for Management

A comprehensive set of evidence-based guidelines encompassing the management of type 1 diabetes, type 2 diabetes, gestational diabetes, and prediabetes is introduced for effective diabetes care.

January 2024

Investigating the Diabetes-Urinary Tract Infection
Investigating the Diabetes-Urinary Tract Infection Link

Study implicates the antimicrobial peptide psoriasin in compromising urinary bladder cellular barriers, linking it to diabetes-related urinary tract infections.

December 2023

Impact of Diabetes on Tooth Enamel and Dentin
Impact of Diabetes on Tooth Enamel and Dentin

Diabetes identified as a factor contributing to weakened tooth structure and increased susceptibility to tooth decay.

December 2023

Vocal Changes Linked to Diabetes
Vocal Changes Linked to Diabetes

Voice analysis as a potential tool for detecting or managing diabetes.

December 2023

Link Between Sleep Deficit and Insulin Resistance
Link Between Sleep Deficit and Insulin Resistance

Lack of adequate sleep identified as a modifiable risk factor contributing to insulin resistance and the development of type 2 diabetes.

December 2023

Blood Pressure and Cardiovascular Mortality in Dia
Blood Pressure and Cardiovascular Mortality in Diabetes

Examining actual blood pressure levels and cardiovascular mortality in patients with type 2 diabetes.

November 2023

Redefining Prevention and Management of Cardiovasc
Redefining Prevention and Management of Cardiovascular Risk

American Heart Association adopts a new approach focused on the interactions between obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease.

November 2023

Link Between Smoking, Prediabetes, and Stroke Risk
Link Between Smoking, Prediabetes, and Stroke Risk

Combined prediabetes and persistent tobacco use substantially elevate the risk of stroke among healthy young adults.

November 2023

Efficacy of Semaglutide in Obesity Without Diabete
Efficacy of Semaglutide in Obesity Without Diabetes

Weekly subcutaneous administration of 2.4 mg semaglutide demonstrates superiority over placebo in treating obesity without diabetes.

November 2023

Tirzepatide versus Insulin Lispro in Basal Insulin
Tirzepatide versus Insulin Lispro in Basal Insulin Regimen

Comparative study demonstrating reductions in HbA1c and body weight with less hypoglycemia using Tirzepatide versus insulin Lispro added to basal insulin.

November 2023